Around The Web

Updates on critical psychiatry postings across the Internet.

Kate Millet Obituary

3
From The Guardian: Kate Millet, the radical feminist who launched the second wave of the women's liberation movement, died on September 6th. Millet was also...

Neuroscientist: To Fight Opioid Addiction, Tackle Loneliness

8
From The Washington Post: "If we don’t have the ability to connect socially, we are so ravenous for our social neurochemistry to be rebalanced, [we'll] seek relief from anywhere."

“Psychiatrists From Another Dimension”

0
Neuroskeptic reviews the implications of the new/old interest in "dimensional" diagnosis in DSM-5 (which involves acknowledgment of symptoms across categories of diagnosis, rather than...

Scuba Diving’s Effects on Flashbacks

3
NPR reports on veterans struggling with traumatic flashbacks who've found peace in exploring underwater. "I went through group therapies. I was actually institutionalized for...

J&J Tries to Block a Reporter from Courtroom

0
Philadelphia Inquirer reporter David Sell writes of Johnson & Johnson's attempt to remove him from the courtroom during jury selection for the upcoming Risperdal...

Many People Taking Antidepressants Discover They Cannot Quit

7
From The New York Times: Global prescription rates and long-term use of antidepressants are rising rapidly. One unanticipated consequence of this trend is that more...

“Royal College Calls for an End to ‘Bashing’ Psychiatrists”

7
“President of the Royal College of Psychiatrists, Professor Sir Simon Wessely is launching a campaign to support medical students and trainee doctors by exposing...

Neuroskeptic and Horgan in Conversation

0
-Discover's Neuroskeptic and Scientific American's John Horgan discuss neuroscience and bad science on Bloggingheads.tv

NIH Hospital Made Patient Safety ‘Subservient to Research’

1
A Washington-Post exclusive reveals that that the leadership of the flagship hospital of the National Institute of Health (NIH) is being restructured after a...

Rats Choose Social Life over Drugs

0
A classic experiment demonstrated that rats who had access to a full social life clearly chose not to ingest opiates, if given the choice,...

Big Pharma: The Global Effect

3
In this piece for Vision Magazine, Danit Felber details the U.S. pharmaceutical industry's efforts to stomp out foreign competition. "What does this mean practically? A nonprofit...

The Psychedelic Miracle

0
From Rolling Stone Magazine: Both the underground practice of and aboveground research on the use of psychedelic drugs to heal PTSD, as well as depression, anxiety,...

Is Mental Illness Real?

3
From The Guardian: Conceptualizing emotional distress or suffering as the result of a biological, genetic illness may be stigmatizing and inaccurate, and may lead to...

Extreme States with Michael Cornwall, PhD | Jung and the World

8
From Jung and the World: Jungian psychotherapist Michael Cornwall talks about his experience helping clients through extreme states (psychosis) for over 40 years.

A Conversation With Ann Bracken, Author of ‘Crash: A Memoir of Overmedication and Recovery’

0
From Medicating Normal: Poet-activist Ann Bracken's new book explores mother-daughter depression, chronic pain experiences, and struggling in a mechanistic and reductionist health-care system.

SUD Patients’ Confidentiality a Quiet Victim of the CARES Act

1
From Filter: "The three possible uses of this information that the Cares Act permits are: treatment, and obviously, you would want treatment providers to...

What Care for the Criminally Insane Can Teach Us

0
In this piece for The Pew Charitable Trusts, Michael Ollove reports on Oregon's model of intense care and supervision for those found guilty except for insanity. "Oregon’s model...

“The Rational Choices of Crack Addicts”

0
The New York Times echoes the "Rat Park" experiment in an article that quotes a researcher: "“Eighty to 90 percent of people who use...

One in Four Resident Physicians Suffer from Depression

1
A new study in JAMA reveals that, on average, 25% of beginning physicians meet the diagnostic criteria for major depression. In an accompanying editorial, Dr. Thomas Schwenk, added: "Everybody asks me, because of some of my prior studies, should we have more intense work in diagnosing depression in students? Of course, the answer is 'yes,' but how do you go about that without further stigmatizing them, further labeling them, further singling them out to even greater stigma? It's not just an issue of, 'Let's make better diagnoses and let's provide better treatment'; it’s more complicated than that."

AMI-Quebec Lecture: Rethinking Psychiatry With Robert Whitaker

1
From AMI-Quebec and the Montreal Gazette: The way drugs shape long-term outcomes must be understood against our natural capacity to recover, said author Robert Whitaker ahead of his public lecture in Montreal.

Co-Responder Teams Changing How Minn. Police Deal With Mental Health Calls

3
From MinnPost: "We can really take the time to listen to somebody; hear what they’re going through; help them feel a little bit understood… it can make a big difference."

Internal Eli Lilly Documents Added to Online Archive

7
Internal Eli Lilly records about the antipsychotic drug Zyprexa have been added to the University of California's online, publicly accessible Drug Industry Documents Archive...

Susie Orbach’s Guide to Books to Understand Yourself

0
In this piece for The Guardian, Susie Orbach argues that we should not turn to the DSM to understand ourselves, but instead to the work of...

“The Post-Irene Mental Health System of Care”

1
-Hurricane Irene seems to have left some community-based approaches to psychiatric care in its wake.

Medical Marketing Has Skyrocketed, While Oversight Remains Limited

2
From Medical Xpress: Direct-to-consumer advertising increased most rapidly, from $2.1 billion (11.9% of total spending) in 1997 to $9.6 billion (32% of total spending) in 2016.